Pathology Companies, December 2014

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

About 200 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

Johnson and Johnson

United States

Eli Lilly and Co.

United States

AstraZeneca PLC

United Kingdom

Bristol-Myers Squibb Co.

United States

Amgen Inc.

United States

Bayer AG

Germany

Lilly and Co.

United States

Celgene Corp.

United States

Abbott Laboratories

United States

Imaging Systems L.L.C.

United States

Genentech Inc.

United States

Gilead Sciences Inc.

United States

Merck KGaA

Germany

Allergan Inc.

United States

Icon Group

United States

Omeros Corp.

United States

Biogen Idec

United States

Immunomedics Inc.

United States


About 4 400 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 10 995)

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

Ulcerative Colitis: Kol Insight

December 2014 $ 8 119

Russia Hiv/aids, Dalys

May 2013 $ 250

Cyprus Hiv/aids, Dalys

May 2013 $ 250

Gambia Gonorrhoea, Dalys

May 2013 $ 250

Moldova Chlamydia, Dalys

May 2013 $ 250

Angola Syphilis, Dalys

May 2013 $ 250

Bahamas Gonorrhoea, Dalys

May 2013 $ 250

Key Pharma News 15 September 2014

September 2014 $ 1 415

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.